Chapter 23 Pharmacology of TMS
暂无分享,去创建一个
[1] H. Bostock,et al. Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking , 2002, Experimental Brain Research.
[2] W. Fischer,et al. Riluzole suppresses motor cortex facilitation in correlation to its plasma level , 2000, Experimental Brain Research.
[3] P. Schwenkreis,et al. Influence of the N-methyl-d-aspartate antagonist memantine on human motor cortex excitability , 1999, Neuroscience Letters.
[4] Diane Ruge,et al. Short‐interval paired‐pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity , 2002, The Journal of physiology.
[5] M. Hallett,et al. Effect of levetiracetam on human corticospinal excitability , 2001, Neurology.
[6] C. Schönfeldt-Lecuona,et al. Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation , 2002, Psychopharmacology.
[7] R. Mutani,et al. Magnetic brain stimulation: the silent period after the motor evoked potential. , 1992, Neurology.
[8] L. Cohen,et al. Noradrenergic modulation of human cortex excitability by the presynaptic α2-antagonist yohimbine , 2001, Neuroscience Letters.
[9] P. Pasqualetti,et al. Ketamine Increases Human Motor Cortex Excitability to Transcranial Magnetic Stimulation , 2003, The Journal of physiology.
[10] J. Liepert,et al. Orally administered atropine enhances motor cortex excitability: a transcranial magnetic stimulation study in human subjects , 2001, Neuroscience Letters.
[11] J C Rothwell,et al. Short latency facilitation between pairs of threshold magnetic stimuli applied to human motor cortex. , 1996, Electroencephalography and clinical neurophysiology.
[12] M Hallett,et al. Dextromethorphan decreases the excitability of the human motor cortex , 1998, Neurology.
[13] Ichiro Kanazawa,et al. Mechanisms of intracortical I‐wave facilitation elicited with paired‐pulse magnetic stimulation in humans , 2002, The Journal of physiology.
[14] K J Werhahn,et al. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans , 1999, The Journal of physiology.
[15] U. Ziemann,et al. Complex modulation of human motor cortex excitability by the specific serotonin re-uptake inhibitor sertraline , 2002, Neuroscience Letters.
[16] B Conrad,et al. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia , 1998, Muscle & nerve.
[17] E. Brunko,et al. Effects of diphenylhydantoin on motor potentials evoked with magnetic stimulation. , 1994, Electroencephalography and clinical neurophysiology.
[18] H. Heinrich,et al. Methylphenidate and intracortical excitability: opposite effects in healthy subjects and attention‐deficit hyperactivity disorder , 2003, Acta psychiatrica Scandinavica.
[19] M. Tegenthoff,et al. The glutamate antagonist Riluzole suppresses intracortical facilitation , 2005, Journal of Neural Transmission.
[20] L. Cohen,et al. Mechanisms influencing stimulus-response properties of the human corticospinal system , 2001, Clinical Neurophysiology.
[21] J. Rothwell,et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand , 2000, The Journal of physiology.
[22] C. Marsden,et al. Corticocortical inhibition in human motor cortex. , 1993, The Journal of physiology.
[23] A. Berardelli,et al. Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans , 1996, Experimental Brain Research.
[24] J. Rothwell,et al. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex , 2000, Clinical Neurophysiology.
[25] N Accornero,et al. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. , 1994, Brain : a journal of neurology.
[26] Ulf Ziemann,et al. The α2-adrenergic agonist guanfacine reduces excitability of human motor cortex through disfacilitation and increase of inhibition , 2003, Clinical Neurophysiology.
[27] W. Paulus,et al. Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study. , 1998, Electroencephalography and clinical neurophysiology.
[28] J. Rothwell,et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex , 2000, Experimental Brain Research.
[29] J. Rothwell,et al. Interaction between intracortical inhibition and facilitation in human motor cortex. , 1996, The Journal of physiology.
[30] U. Ziemann,et al. Methylphenidate facilitates and disinhibits the motor cortex in intact humans , 2003, Neuroreport.
[31] Janine Reis,et al. Topiramate Selectively Decreases Intracortical Excitability in Human Motor Cortex , 2002, Epilepsia.
[32] W. Paulus,et al. Piracetam affects facilitatory I-wave interaction in the human motor cortex , 2001, Clinical Neurophysiology.
[33] Walter Paulus,et al. Demonstration of facilitatory I wave interaction in the human motor cortex by paired transcranial magnetic stimulation , 1998, The Journal of physiology.
[34] L. Cohen,et al. Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine , 2002, Neuroscience Letters.
[35] B. Steinhoff,et al. Effects of antiepileptic drugs on motor cortex excitability in humans: A transcranial magnetic stimulation study , 1996, Annals of neurology.
[36] Walter Paulus,et al. Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation , 1996, Neuroscience Letters.
[37] J C Rothwell,et al. Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans. , 1998, Electroencephalography and clinical neurophysiology.
[38] J. Rothwell,et al. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation , 2002, Neurology.
[39] W Paulus,et al. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. , 1997, Electroencephalography and clinical neurophysiology.
[40] M Hallett,et al. Effects of phenytoin on cortical excitability in humans , 1997, Neurology.
[41] Walter Paulus,et al. The effect of lorazepam on the motor cortical excitability in man , 1996, Experimental Brain Research.